Medical marijuana for the treatment of vismodegib-related muscle spasm
Keywords: basal cell carcinoma, medical marijuana, muscle cramps, vismodegib, BCC, basal cell carcinoma, CBD, cannabidiol, FDA, US Food and Drug…
Multiple sclerosis
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
Abstract The global exposure of Sativex® (Δ9-tetrahydrocannabinol [THC]:cannabidiol [CBD], nabiximols) is estimated to be above 45,000 patient-years since it was…
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
Abstract Medicine continues to struggle in its approaches to numerous common subjective pain syndromes that lack objective signs and remain…
Medicinal Cannabis in California: An Interview with Igor Grant, MD
Abstract Dr. Igor Grant, MD, is distinguished professor and chair of psychiatry and director of the HIV Neurobehavioral Research Program…
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
Abstract Background: The present study was designed to investigate the efficacy of a new formulation of alone, purified cannabidiol (CBD)…
Symptomatic management in multiple sclerosis
Abstract Multiple sclerosis (MS) is the commonest cause of disability in young adults. While there is increasing choice and better…
Cannabis-induced alterations in brain activation during a test of information processing speed in patients with MS
Abstract Objective: The objective of this article is to determine the functional brain correlates of information processing speed in multiple…
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
Abstract The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and…
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models
Abstract In patients with multiple sclerosis (MS), pain is a frequent and disabling symptom. The prevalence is in the range…
A mechanism-based classification of pain in multiple sclerosis
Abstract Pharmacological treatment of pain in multiple sclerosis (MS) is challenging due to the many underlying pathophysiological mechanisms. Few controlled…